All compounds
HealingRecovery
TB-500
Thymosin Beta-4 Fragment | Recovery
Typical Dose
2–10 mg weekly
Route
Injectable
Variants
10mg
Overview
What is TB-500?
TB-500 is a synthetic version of the active region of Thymosin Beta-4, studied for systemic healing, angiogenesis and tissue regeneration.
Mechanism of Action
Upregulates actin and promotes endothelial cell migration, supporting angiogenesis and tissue remodeling.
Key Benefits
- Full-body healing
- Improved flexibility and mobility
- Angiogenesis support
Research Indications
Soft-tissue injuryMost Effective
Chronic inflammationEffective
Joint mobilityEffective
Research Protocols
Disclaimer
These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Conservative | 2 mg | 2x weekly | Subcutaneous |
| Standard starting dose | 5 mg | 2x weekly (loading 4 wks) | Subcutaneous |
| Typical maintenance | 5 mg | 1x weekly | Subcutaneous |
| Maximum | 10 mg | 1x weekly | Subcutaneous |
Peptide Interactions
BPC-157
GHK-Cu
Side Effects & Safety
Common Side Effects
- Mild lethargy first dose
- Head rush
- Injection-site reaction
Safety Guidelines
- For laboratory research use only — not for human consumption
- Store reconstituted vials at 2–8°C, use within 30 days
- Rotate injection sites to avoid local irritation
- Discontinue and consult a clinician if adverse reactions occur
Quality Indicators
- ≥95% purity verified by HPLC
- Third-party tested for sterility
- Lyophilized in sealed multi-dose vial
- Bacteriostatic water reconstitution
- Refrigerated cold-chain shipping
What to Expect
- 1Week 1–2Reduced pain, improved mobility
- 2Week 3–6Tissue repair acceleration
- 3Week 7–8Sustained recovery, taper to maintenance
Need a different compound?
Browse all peptides